logo

For the Inventor, By the Inventor

Lorrach, Germany

Siem Jacob Veenstra

This inventor holds 17 USPTO granted patents and 6 published patent applications and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignee: Novartis Ag. Active years: 2000-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Siem Jacob Veenstra. Retrieved from https://idiyas.com/inventor/siem-jacob-veenstra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 17 

% Patents Active = 70.6

 

Average Co-Inventor Count = 3.5

ph-index = 5

Forward Citations = 134(Granted Patents)


Location History:

  • Lörrach, DE (2009 - 2012)
  • Loerrach, DE (2014)
  • Lorrach, DE (2000 - 2020)

Company Filing History:

goldMedal17 out of 3,978 
 
Novartis Ag
 patents

Years Active: 2000-2020

Loading Chart...
Loading Chart...
Areas of Expertise:
Heterocyclic Derivatives
BACE Inhibitors
Oxazine Derivatives
Neurological Disorders
Aroyl-Piperidine
Cyclic Sulfones
Macrocyclic Compounds
Dibenzo[b,f]oxepine
Pharmaceutical Uses
Substituted Aminoalkane
Tetrahydro-Quinoxalinyl
17 patents (USPTO):Explore Patents
1. 10683287 - Heterocyclic derivatives and their use in the treatment of neurological disorders (2020-06-16),
2. 10301296 - Heterocyclic derivatives and their use in the treatment of neurological disorders (2019-05-28),
3. 10035794 - Heterocyclic derivatives and their use in the treatment of neurological disorders (2018-07-31),
4. 9550758 - Heterocyclic derivatives and their use in the treatment of neurological disorders (2017-01-24),
5. 9284284 - Oxazine derivatives and their use in the treatment of disease (2016-03-15),
6. 9163011 - Oxazine derivatives and their use in the treatment of disease (2015-10-20),
7. 8865712 - Heterocyclic derivatives and their use in the treatment of neurological disorders (2014-10-21),
8. 8846658 - Oxazine derivatives and their use in the treatment of neurological disorders (2014-09-30),
9. 8637508 - Heterocyclic derivatives and their use in the treatment of neurological disorders (2014-01-28),
10. 8193218 - Aroyl-piperidine derivatives and method of treating disorders induced by substance P (2012-06-05),
11. 8093406 - Cyclic sulfones with aminobenzyl substitution useful as BACE inhibitors (2012-01-10),
12. 8039455 - Macrocyclic compounds useful as BACE inhibitors (2011-10-18),
13. 7678814 - Aroyl-piperidine derivatives (2010-03-16),
14. 7612055 - Macrocyclic lactams and pharmaceutical use thereof (2009-11-03),
15. 7612054 - Dibenzo[b,f]oxepine-10-carboxamides and pharmaceutical uses thereof (2009-11-03),

Title: The Innovative Journey of Siem Jacob Veenstra

Introduction:

Siem Jacob Veenstra, a talented inventor hailing from Lorrach, Germany, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents:

Siem Jacob Veenstra's latest patents showcase his commitment to pushing the boundaries of technological advancement, with a focus on improving efficiency and functionality in various industries.

Career Highlights:

Throughout his illustrious career, Siem Jacob Veenstra has demonstrated a keen ability to identify gaps in the market and develop innovative solutions to address them. His work has not only earned him recognition within the industry but has also positively impacted the lives of many.

Collaborations:

Siem Jacob Veenstra has collaborated with leading experts and organizations in the technology sector to bring his inventions to life. These collaborations have been instrumental in the successful implementation of his ideas and have paved the way for future innovations.

Conclusion:

In conclusion, Siem Jacob Veenstra's passion for innovation and his dedication to creating cutting-edge solutions have solidified his reputation as a pioneering inventor in the field of technology. His contributions continue to inspire and shape the future of technological advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…